Form 4 Tracker
Christine Ann Fox

Chief Financial Officer · 1 filing · Latest: Feb 1, 2026

Mereo BioPharma Group plc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MREO
Fox Christine AnnSep 12, 2024
Proposed Sale
$4.6628,286$131.8K